Effects of Genes and Stress on the Neurobiology of Depression

International Review of Neurobiology

Volumn 73, Issue , 2006, Pages 153-189

  Mann, J John ^a   Currier, Dianne ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL; DEPRESSION; GENETICS; HUMAN; METABOLISM; NEUROBIOLOGY; NEUROSECRETION; PATHOPHYSIOLOGY; REVIEW; STRESS;

ANIMALS; BIOGENIC MONOAMINES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; HUMANS; NEUROBIOLOGY; NEUROSECRETORY SYSTEMS; STRESS;

EID: 33646840434     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(06)73005-7     Document Type: Review

References (235)

1. Abercrombie E.D., and Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli. J. Neurosci. 7 (1987) 2844-2848
2. Abkevich V., Camp N.J., Hensel C.H., Neff C.D., Russell D.L., Hughes D.C., Plenk A.M., Lowry M.R., Richards R.L., Carter C., Frech G.C., Stone S., et al. Predisposition locus for major depression at chromosome 12q22-12q23.2. Am. J. Hum. Genet. 73 (2003) 1271-1281
3. Adams J.H., Wigg K.G., King N., Burcescu I., Vetro A., Kiss E., Baji I., George C.J., Kennedy J.L., Kovacs M., and Barr C.L. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders. Am. J. Med. Genet. 132 1 (2003) 90-95
4. Adell A., Casanovas J.M., and Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 36 (1997) 735-741
5. Al Damluji S., Ross G., Touzel R., Perrett D., White A., and Besser G.M. Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade. Br. J. Pharmacol. 95 (1988) 405-412
6. American Psychiatric Association. "Diagnostic and Statistical Manual for Mental Disorders, DSM-IV." (1994), American Psychiatric Association, Washington, DC
7. Amsterdam J.D., Maislin G., Winokur A., Berwish N., Kling M., and Gold P. The oCRH stimulation test before and after clinical recovery from depression. J. Affect. Disorders 14 (1988) 213-222
8. Amsterdam J.D., Marinelli D.L., Arger P., and Winokur A. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study. Psychiatry Res. 21 (1987) 189-197
9. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter. I. Affective disorders. Mol. Psychiatry 8 (2003) 574-591
10. Ansorge M.S., Zhou M., Lira A., Hen R., and Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004) 879-881
11. 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res. 630 (1993) 271-282
12. Arango V., Underwood M.D., and Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results. Biol. Psychiatry 39 (1996) 112-120
13. Arató M., Banki C.M., Nemeroff C.B., and Bissette G. Hypothalamic-pituitary-adrenal axis and suicide. Ann. NY. Acad. Sci. 487 (1986) 263-270
14. Arborelius L., Hawks B.W., Owens M.J., Plotsky P.M., and Nemeroff C.B. Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation. Psychopharmacology (Berlin) 176 (2004) 248-255
15. Arias B., Catalan R., Gasto C., Gutierrez B., and Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J. Clin. Psychopharmacol. 23 (2003) 563-567
16. Arias B., Collier D.A., Gasto C., Pintor L., Gutierrez B., Valles V., and Fananas L. Genetic variation in the 5-HT5A receptor gene in patients with bipolar disorder and major depression. Neurosci. Lett. 303 (2001) 111-114
17. Asberg M., Bertilsson L., Martensson B., Scalia-Tomba G.P., Thoren P., and Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr. Scand. 69 (1984) 201-219
18. Austin M.C., Rice P.M., Mann J.J., and Arango V. Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: An immunocytochemical and in situ hybridization study. Neuroscience 64 (1995) 713-727
19. Avishai-Eliner S., Eghbal-Ahmadi M., Tabachnik E., Brunson K.L., and Baram T.Z. Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA. Endocrinology 142 (2001) 89-97
20. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 73 (1996) 277-280
21. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 134 (1994) 1127-1131
22. Baghai T.C., Schule C., Zwanzger P., Minov C., Zill P., Ella R., Eser D., Oezer S., Bondy B., and Rupprecht R. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci. Lett. 328 (2002) 299-303
23. Banki C.M., Bissette G., Arato M., O'Connor L., and Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry 144 (1987) 873-877
24. Banki C.M., Karmacsi L., Bissette G., and Nemeroff C.B. CSF corticotropin-releasing hormone and somatostatin in major depression: Response to antidepressant treatment and relapse. Eur. Neuropsychopharmacol. 2 (1992) 107-113
25. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
26. Baron M. Manic-depression genes and the new millennium: Poised for discovery. Mol. Psychiatry 7 (2002) 342-358
27. Barr C.S., Newman T.K., Shannon C., Parker C., Dvoskin R.L., Becker M.L., Schwandt M., Champoux M., Lesch K.P., Goldman D., Suomi S.J., and Higley J.D. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol. Psychiatry 55 (2004) 733-738
28. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 52 (2002) 708-715
29. Bellivier F., Leboyer M., Courtet P., Buresi C., Beaufils B., Samolyk D., Allilaire J.F., Feingold J., Mallet J., and Malafosse A. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch. Gen. Psychiatry 55 (1998) 33-37
30. Bellivier F., Roy I., and Leboyer M. Serotonin transporter gene polymorphisms and affective disorder-related phenotypes. Curr. Opin. Psychiatr. 15 (2002) 49-58
31. Benes F.M., Todtenkopf M.S., and Kostoulakos P. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11 (2001) 482-491
32. Benes F.M., Todtenkopf M.S., Logiotatos P., and Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20 (2000) 259-269
33. Bennett A.J., Lesch K.P., Heils A., Long J.C., Lorenz J.G., Shoaf S.E., Champoux M., Suomi S.J., Linnoila M.V., and Higley J.D. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry 7 (2002) 118-122
34. Berrettini W.H. Molecular linkage studies of bipolar disorders. Bipolar Disord. 3 (2001) 276-283
35. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., Papiol S., Seaman S., Lucae S., Kohli M.A., Nickel T., Kunzel H.E., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36 (2004) 1319-1325
36. Birkett J.T., Arranz M.J., Munro J., Osbourn S., Kerwin R.W., and Collier D.A. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 11 (2000) 2017-2020
37. Boldrini M., Underwood M.D., Mann J.J., and Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 1041 (2005) 19-28
38. Brake W.G., Zhang T.Y., Diorio J., Meaney M.J., and Gratton A. Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur. J. Neurosci. 19 (2004) 1863-1874
39. Bray N.J., Buckland P.R., Hall H., Owen M.J., and O'Donovan M.C. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol. Psychiatry 9 (2004) 109-114
40. Breier A.A.E. Bennett award paper. Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol. Psychiatry 26 (1989) 438-462
41. Brostedt E.M., and Pedersen N.L. Stressful life events and affective illness. Acta Psychiatr. Scand. 107 (2003) 208-215
42. Brunson K.L., Avishai-Eliner S., Hatalski C.G., and Baram T.Z. Neurobiology of the stress response early in life: Evolution of a concept and the role of corticotropin releasing hormone. Mol. Psychiatry 6 (2001) 647-656
43. Caldji C., Francis D., Sharma S., Plotsky P.M., and Meaney M.J. The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. Neuropsychopharmacology 22 (2000) 219-229
44. Calogero A.E., Bernardini R., Margioris A.N., Bagdy G., Gallucci W.T., Munson P.J., Tamarkin L., Tomai T.P., Brady L., and Gold P.W. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10 (1989) 189-200
45. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
46. Carroll B.J. 5-hydroxytryptamine in the hindbrain of depressive suicides. Br. J. Psychiatry 114 (1968) 782-783
47. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
48. Cassens G., Roffman M., Kuruc A., Orsulak P.J., and Schildkraut J.J. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science 209 (1980) 1138-1140
49. Chamas F., Serova L., and Sabban E.L. Tryptophan hydroxylase mRNA levels are elevated by repeated immobilization stress in rat raphe nuclei but not in pineal gland. Neurosci. Lett. 267 (1999) 157-160
50. Chamas F.M., Underwood M.D., Arango V., Serova L., Kassir S.A., Mann J.J., and Sabban E.L. Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei. Biol. Psychiatry 55 (2004) 278-283
51. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59 Suppl. 14 (1998) 11-14
52. Chiaroni P., Azorin J.M., Dassa D., Henry J.M., Giudicelli S., Malthiery Y., and Planells R. Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder. Psychiatr. Genet. 10 (2000) 43-49
53. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Muller C.R., Roberts G.W., et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol. Psychiatry 1 (1996) 453-460
54. Craddock N., Dave S., and Greening J. Association studies of bipolar disorder. Bipolar Disord. 3 (2001) 284-298
55. Craddock N., and Jones I. Genetics of bipolar disorder. J. Med. Genet. 36 (1999) 585-594
56. Curtis A.L., Bello N.T., Connolly K.R., and Valentino R.J. Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J. Neuroendocrinol. 14 (2002) 667-682
57. Curtis A.L., Lechner S.M., Pavcovich L.A., and Valentino R.J. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: Effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281 (1997) 163-172
58. Daniels W.M., Pietersen C.Y., Carstens M.E., and Stein D.J. Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab. Brain Dis. 19 (2004) 3-14
59. De bruyn A., Mendelbaum K., Sandkuijl L.A., Delvenne V., Hirsch D., Staner L., Mendlewicz J., and Van Broeckhoven C. Nonlinkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. Am. J. Psychiatry 151 (1994) 102-106
60. De Luca V., Mueller D.J., Tharmalingam S., King N., and Kennedy J.L. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol. Psychiatry 9 (2004) 896-897
61. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L.E., and Horton R.W. Brain b-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res. 525 (1990) 71-77
62. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Heninger G.R., Gelenberg A.J., and Charney D.S. Monoamines and the mechanism of antidepressant action: Effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol. Bull. 29 (1993) 389-396
63. Duffy A., Turecki G., Grof P., Cavazzoni P., Grof E., Joober R., Ahrens B., Berghofer A., Muller-Oerlinghausen B., Dvorakova M., Libigerova E., Vojtechovsky M., et al. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. J. Psychiatry Neurosci. 25 (2000) 353-358
64. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
65. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46 (1999) 1181-1191
66. Dunn A.J. Changes in plasma and brain tryptophan and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress. Life Sci. 42 (1988) 1847-1853
67. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
68. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., and Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry 9 (2004) 908-915
69. Elvidge G., Jones I., McCandless F., Asherson P., Owen M.J., and Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis. Am. J. Med. Genet. 105 (2001) 307-311
70. Etain B., Rousseva A., Roy I., Henry C., Malafosse A., Buresi C., Preisig M., Rayah F., Leboyer M., and Bellivier F. Lack of association between 5HT2A receptor gene haplotype, bipolar disorder and its clinical subtypes in a West European sample. Am. J. Med. Genet. 129B (2004) 29-33
71. Fang H., Chartier J., Sodja C., Desbois A., Ribecco-Lutkiewicz M., Walker P.R., and Sikorska M. Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons. J. Biol. Chem. 278 (2003) 26401-26409
72. Fehr C., Grintschuk N., Szegedi A., Anghelescu I., Klawe C., Singer P., Hiemke C., and Dahmen N. The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res. 97 (2000) 1-10
73. Feldman S., and Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology 16 (1991) 397-405
74. Finlay J.M., and Zigmond M.J. The effects of stress on central dopaminergic neurons: Possible clinical implications. Neurochem. Res. 22 (1997) 1387-1394
75. Fiskerstrand C.E., Lovejoy E.A., and Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett. 458 (1999) 171-174
76. Frisch A., Postilnick D., Rockah R., Michaelovsky E., Postilnick S., Birman E., Laor N., Rauchverger B., Kreinin A., Poyurovsky M., Schneidman M., Modai I., et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 4 (1999) 389-392
77. Fuchs E., and Flugge G. Chronic social stress: Effects on limbic brain structures. Physiol. Behav. 79 (2003) 417-427
78. Furlong R.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., and Rubinsztein D.C. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am. J. Med. Genet. 81 (1998) 245-247
79. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., and Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am. J. Med. Genet. 81 (1998) 58-63
80. Furmark T., Tillfors M., Garpenstrand H., Marteinsdottir I., Langstrom B., Oreland L., and Fredrikson M. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci. Lett. 362 (2004) 189-192
81. Gold B.I., Bowers Jr. M.B., Roth R.H., and Sweeney D.W. GABA levels in CSF of patients with psychiatric disorders. Am. J. Psychiatry 137 (1980) 362-364
82. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., and Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88 (1999) 83-87
83. Habib K.E., Gold P.W., and Chrousos G.P. Neuroendocrinology of stress. Endocrinol. Metab. Clin. North Am. 30 (2001) 695-728
84. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., and Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 62 (2005) 146-152
85. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
86. Hashimoto S., Inoue T., and Koyama T. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur. J. Pharmacol. 378 (1999) 23-30
87. Heim C., Newport D.J., Bonsall R., Miller A.H., and Nemeroff C.B. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am. J. Psychiatry 158 (2001) 575-581
88. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., Miller A.H., and Nemeroff C.B. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. J. Am. Med. Assoc. 284 (2000) 592-597
89. Heim C., Newport D.J., Wagner D., Wilcox M.M., Miller A.H., and Nemeroff C.B. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: A multiple regression analysis. Depress Anxiety 15 (2002) 117-125
90. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., and Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8 (2005) 20-21
91. Heinz A., Mann K., Weinberger D.R., and Goldman D. Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin. Exp. Res. 25 (2001) 487-495
92. Henderson A.S., Korten A.E., Jorm A.F., Jacomb P.A., Christensen H., Rodgers B., Tan X., and Easteal S. COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am. J. Med. Genet. 96 (2000) 102-107
93. Henkel V., Baghai T.C., Eser D., Zill P., Mergl R., Zwanzger P., Schule C., Bottlender R., Jager M., Rupprecht R., Hegerl U., Moller H.J., et al. The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: A genetic association study. Am. J. Med. Genet. 126B (2004) 82-87
94. Holmans P., Zubenko G.S., Crowe R.R., DePaulo Jr. J.R., Scheftner W.A., Weissman M.M., Zubenko W.N., Boutelle S., Murphy-Eberenz K., MacKinnon D., McInnis M.G., Marta D.H., et al. Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am. J. Hum. Genet. 74 (2004) 1154-1167
95. Hong C.J., Huo S.J., Yen F.C., Tung C.L., Pan G.M., and Tsai S.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48 (2003) 186-189
96. Hong C.J., Tsai S.J., Cheng C.Y., Liao W.Y., Song H.L., and Lai H.C. Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. Am. J. Med. Genet. 88 (1999) 601-602
97. Horger B.A., and Roth R.H. The role of mesoprefrontal dopamine neurons in stress. Crit. Rev. Neurobiol. 10 (1996) 395-418
98. Horiuchi Y., Nakayama J., Ishiguro H., Ohtsuki T., Detera-Wadleigh S.D., Toyota T., Yamada K., Nankai M., Shibuya H., Yoshikawa T., and Arinami T. Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders. Biol. Psychiatry 55 (2004) 40-45
99. Hrdina P.D., and Du L. Levels of serotonin receptor 2A higher in suicide victims?. Am. J. Psychiatry 158 (2001) 147-148
100. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., and Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin. Exp. Res. 29 (2005) 8-16
101. Huang Y.Y., Oquendo M.A., Harkavy-Friedman J.M., Greenhill L.L., Brodsky B., Malone K.M., Khait V., and Mann J.J. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 28 (2003) 163-169
102. Jedema H.P., and Grace A.A. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J. Neurosci. 24 (2004) 9703-9713
103. Jonsson E.G., Nothen M.M., Gustavsson J.P., Neidt H., Bunzel R., Propping P., and Sedvall G.C. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res. 79 (1998) 1-9
104. Kaiser R., Muller-Oerlinghausen B., Filler D., Tremblay P.B., Berghofer A., Roots I., and Brockmoller J. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am. J. Med. Genet. 114 (2002) 323-328
105. Kapur S., and Mann J.J. Role of the dopaminergic system in depression. Biol. Psychiatry 32 (1992) 1-17
106. Kathol R.G., Jaeckle R.S., Lopez J.F., and Meller W.H. Pathophysiology of HPA axis abnormalities in patients with major depression: An update. Am. J. Psychiatry 146 (1989) 311-317
107. Kaufman J., Birmaher B., Perel J., Dahl R.E., Stull S., Brent D., Trubnick L., al Shabbout M., and Ryan N.D. Serotonergic functioning in depressed abused children: Clinical and familial correlates. Biol. Psychiatry 44 (1998) 973-981
108. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., and Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl. Acad. Sci. USA 101 (2004) 17316-17321
109. Keller M.B., Lavori P.W., Rice J., Coryell W., and Hirschfeld R.M. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up. Am. J. Psychiatry 143 (1986) 24-28
110. Kendler K.S., and Karkowski-Shuman L. Stressful life events and genetic liability to major depression: Genetic control of exposure to the environment?. Psychol. Med. 27 (1997) 539-547
111. Kendler K.S., Karkowski L.M., and Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 156 (1999) 837-841
112. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., and Eaves L.J. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am. J. Psychiatry 152 (1995) 833-842
113. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Childhood parental loss and adult psychopathology in women. A twin study perspective. Arch. Gen. Psychiatry 49 (1992) 109-116
114. Kendler K.S., Thornton L.M., and Prescott C.A. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am. J. Psychiatry 158 (2001) 587-593
115. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Huges M., Eshleman S., Wittchen H.U., and Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch. Gen. Psychiatry 51 (1994) 8-19
116. Khait V.D., Huang Y.Y., Zalsman G., Oquendo M.A., Brent D.A., Harkavy-Friedman J.M., and Mann J.J. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 30 (2005) 166-172
117. Kirov G., Owen M.J., Jones I., McCandless F., and Craddock N. Tryptophan hydroxylase gene and manic-depressive illness. Arch. Gen. Psychiatry 56 (1999) 98-99
118. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., and Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17 (1997) 8451-8458
119. Koslow S.H., Maas J.W., Bowden C.L., David J.M., Hanin I., and Javaid J. CSF and urinary biogenic amines and metabolism in depression and mania. A controlled univariate analysis. Arch. Gen. Psychiatry 40 (1983) 999-1010
120. Kraemer G.W., Ebert M.H., Schmidt D.E., and McKinney W.T. A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. Neuropsychopharmacology 2 (1989) 175-189
121. Krishnan K.R.R., Doraiswamy P.M., Lurie S.N., Figiel G.S., Husain M.M., Boyko O.B., Ellinwood Jr. E.H., and Nemeroff C.B. Pituitary size in depression. J. Clin. Endocrinol. Metab. 72 (1991) 256-259
122. Kunugi H., Ishida S., Kato T., Sakai T., Tatsumi M., Hirose T., and Nanko S. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am. J. Psychiatry 156 (1999) 774-776
123. Lasky-Su J.A., Faraone S.V., Glatt S.J., and Tsuang M.T. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133 (2005) 110-115
124. Leonard B.E. The role of noradrenaline in depression: A review. J. Psychopharmacol. 11 (1997) S39-S47
125. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
126. Leszczynska-Rodziewicz A., Czerski P.M., Kapelski P., Godlewski S., Dmitrzak-Weglarz M., Rybakowski J., and Hauser J. A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: Lack of association. Neuropsychobiology 45 (2002) 182-185
127. Li T., Liu X., Sham P.C., Aitchison K.J., Cai G., Arranz M.J., Deng H., Liu J., Kirov G., Murray R.M., and Collier D.A. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Res. 86 (1999) 193-201
128. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., and Hofer M.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54 (2003) 960-971
129. Liu D., Caldji C., Sharma S., Plotsky P.M., and Meaney M.J. Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinepherine release in the hypothalamic paraventricular nucleus. J. Neuroendocrinol. 12 (2000) 5-12
130. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., Sharma S., Pearson D., Plotsky P.M., and Meaney M.J. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277 (1997) 1659-1662
131. Lotrich F.E., and Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr. Genet. 14 (2004) 121-129
132. Lovejoy E.A., Scott A.C., Fiskerstrand C.E., Bubb V.J., and Quinn J.P. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur. J. Neurosci. 17 (2003) 417-420
133. MacKenzie A., and Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc. Natl. Acad. Sci. USA 96 (1999) 15251-15255
134. Malone K.M., and Mann J.J. Serotonin and major depression. In: Mann J.J., and Kupfer D.J. (Eds). "Biology of Depressive Disorders, Volume 3, Part A: A System Perspective" (1993), Plenum Press, New York 29-49
135. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 (1995) 7929-7939
136. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
137. Manki H., Kanba S., Muramatsu T., Higuchi S., Suzuki E., Matsushita S., Ono Y., Chiba H., Shintani F., Nakamura M., Yagi G., and Asai M. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J. Affect. Disord. 40 (1996) 7-13
138. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 4 (2003) 819-828
139. Mann J.J., Currier D., Quiroz J., and Manji H.K. Neurobiology of severe mood and anxiety disorders. In: Siegel G.J., Albers R.W., Brady S., and Price D. (Eds). "Basic Neurochemistry". 7th edn. (2005), Elsevier, San Diego
140. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., and Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 57 (2000) 729-738
141. Mann J.J., Malone K.M., Nielsen D.A., Goldman D., Erdos J., and Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am. J. Psychiatry 154 (1997) 1451-1453
142. Massat I., Souery D., Del Favero J., Oruc L., Noethen M.M., Blackwood D., Thomson M., Muir W., Papadimitriou G.N., Dikeos D.G., Kaneva R., Serretti A., et al. Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: A multicentric association study. Mol. Psychiatry 7 (2002) 201-207
143. Massat I., Souery D., Del Favero J., Van Gestel S., Serretti A., Macciardi F., Smeraldi E., Kaneva R., Adolfsson R., Nylander P.O., Blackwood D., Muir W., et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am. J. Med. Genet. 114 (2002) 177-185
144. Mayeux R., Stern Y., Rosen J., and Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology 31 (1981) 645-650
145. McGuffin P., Katz R., Watkins S., and Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch. Gen. Psychiatry 53 (1996) 129-136
146. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., and Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60 (2003) 497-502
147. McQuillin A., Lawrence J., Kalsi G., Chen A., Gurling H., and Curtis D. No allelic association between bipolar affective disorder and the tryptophan hydroxylase gene. Arch. Gen. Psychiatry 56 (1999) 99-101
148. Meaney M.J., Diorio J., Francis D., Widdowson J., LaPlante P., Caldji C., Sharma S., Seckl J.R., and Plotsky P.M. Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev. Neurosci. 18 (1996) 49-72
149. Melia K.R., Rasmussen K., Terwilliger R.Z., Haycock J.W., Nestler E.J., and Duman R.S. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: Effects of chronic stress and drug treatments. J. Neurochem. 58 (1992) 494-502
150. Morilak D.A., Fornal C.A., and Jacobs B.L. Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. II. Cardiovascular challenge. Brain Res. 422 (1987) 24-31
151. Mossner R., Daniel S., Albert D., Heils A., Okladnova O., Schmitt A., and Lesch K.P. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem. Int. 36 (2000) 197-202
152. Mueller T.I., Leon A.C., Keller M.B., Solomon D.A., Endicott J., Coryell W., Warshaw M., and Maser J.D. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am. J. Psychiatry 156 (1999) 1000-1006
153. Murphy D.L., Li Q., Engel S., Wichems C., Andrews A., Lesch K.P., and Uhl G. Genetic perspectives on the serotonin transporter. Brain Res. Bull. 56 (2001) 487-494
154. Nakamura M., Ueno S., Sano A., and Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5 (2000) 32-38
155. Nakata K., Ujike H., Sakai A., Uchida N., Nomura A., Imamura T., Katsu T., Tanaka Y., Hamamura T., and Kuroda S. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 337 (2003) 17-20
156. Nankova B.B., Tank A.W., and Sabban E.L. Transient or sustained transcriptional activation of the genes encoding rat adrenomedullary catecholamine biosynthetic enzymes by different durations of immobilization stress. Neuroscience 94 (1999) 803-808
157. Narrow W.E., Rae D.S., Robins L.N., and Regier D.A. Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile 2 surveys' estimates. Arch. Gen. Psychiatry 59 (2002) 115-123
158. Nelson E.C., Heath A.C., Madden P.A., Cooper M.L., Dinwiddie S.H., Bucholz K.K., Glowinski A., McLaughlin T., Dunne M.P., Statham D.J., and Martin N.G. Association between self-reported childhood sexual abuse and adverse psychosocial outcomes: Results from a twin study. Arch. Gen. Psychiatry 59 (2002) 139-145
159. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
160. Niesler B., Flohr T., Nothen M.M., Fischer C., Rietschel M., Franzek E., Albus M., Propping P., and Rappold G.A. Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 11 (2001) 471-475
161. Nisenbaum L.K., and Abercrombie E.D. Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats. Brain Res. 608 (1993) 280-287
162. Nisenbaum L.K., Zigmond M.J., Sved A.F., and Abercrombie E.D. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J. Neurosci. 11 (1991) 1478-1484
163. Ohara K., Nagai M., Tani K., Tsukamoto T., Suzuki Y., and Ohara K. Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders. Neuroreport 9 (1998) 1291-1294
164. Ohtsuki T., Ishiguro H., Detera-Wadleigh S.D., Toyota T., Shimizu H., Yamada K., Yoshitsugu K., Hattori E., Yoshikawa T., and Arinami T. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol. Psychiatry 7 (2002) 954-961
165. Ono H., Shirakawa O., Kitamura N., Hashimoto T., Nishiguchi N., Nishimura A., Nushida H., Ueno Y., and Maeda K. Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol. Psychiatry 7 (2002) 1127-1132
166. Oquendo M.A., Barrera A., Ellis S.P., Li S., Burke A.K., Grunebaum M., Endicott J., and Mann J.J. Instability of symptoms in recurrent major depression: A prospective study. Am. J. Psychiatry 161 (2004) 255-261
167. Oruc L., Verheyen G.R., Furac I., Ivezic S., Jakovljevic M., Raeymaekers P., and Van Broeckhoven C. Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology 36 (1997) 62-64
168. Oruc L., Verheyen G.R., Furac I., Jakovljevic M., Ivezic S., Raeymaekers P., and Van Broeckhoven C. Analysis of the tyrosine hydroxylase and dopamine D4 receptor genes in a Croatian sample of bipolar I and unipolar patients. Am. J. Med. Genet. 74 (1997) 176-178
169. Oswald P., Souery D., Massat I., Del Favero J., Linotte S., Papadimitriou G., Dikeos D., Kaneva R., Milanova V., Oruc L., Ivezic S., Serretti A., et al. Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study. Eur. Neuropsychopharmacol. 13 (2003) 365-368
170. Owen D., Du L., Bakish D., Lapierre Y.D., and Hrdina P.D. Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res. 87 (1999) 1-5
171. Papadimitriou G.N., Dikeos D.G., Karadima G., Avramopoulos D., Daskalopoulou E.G., and Stefanis C.N. GABA-A receptor beta3 and alpha5 subunit gene cluster on chromosome 15q11-q13 and bipolar disorder: A genetic association study. Am. J. Med. Genet. 105 (2001) 317-320
172. Papadimitriou G.N., Dikeos D.G., Karadima G., Avramopoulos D., Daskalopoulou E.G., Vassilopoulos D., and Stefanis C.N. Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder. Am. J. Med. Genet. 81 (1998) 73-80
173. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman O., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter in the human brain. Am. J. Psychiatry 163 (2005) 48-51
174. Petty F., and Schlesser M.A. Plasma GABA in affective illness. A preliminary investigation. J. Affect. Disord. 3 (1981) 339-343
175. Pine D.S., Coplan J.D., Wasserman G.A., Miller L.S., Fried J.E., Davies M., Cooper T.B., Greenhill L., Shaffer D., and Parsons B. Neuroendocrine response to fenfluramine challenge in boys: Associations with aggressive behavior and adverse rearing. Arch. Gen. Psychiatry 54 (1997) 839-846
176. Plotsky P.M., and Meaney M.J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res. Mol. Brain Res. 18 (1993) 195-200
177. Polesskaya O.O., and Sokolov B.P. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67 (2002) 812-822
178. Pollock B.G., Ferrell R.E., Mulsant B.H., Mazumdar S., Miller M., Sweet R.A., Davis S., Kirshner M.A., Houck P.R., Stack J.A., Reynolds C.F., and Kupfer D.J. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23 (2000) 587-590
179. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21 (2001) 2833-2841
180. Raadsheer F.C., Van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J.G., Tilders F.J.H., and Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 152 (1995) 1372-1376
181. Regier D.A., Narrow W.E., Rae D.S., Manderscheid R.W., Locke B.Z., and Goodwin F.K. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry 50 (1993) 85-94
182. Reist C., Mazzanti C., Vu R., Tran D., and Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am. J. Med. Genet. 105 (2001) 363-368
183. Rietschel M., Schorr A., Albus M., Franzek E., Kreiner R., Held T., Knapp M., Muller D.J., Schulze T.G., Propping P., Maier W., and Nothen M.M. Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls. Am. J. Med. Genet. 96 (2000) 310-311
184. Rinne T., Westenberg H.G., Den Boer J.A., and van den B.W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol. Psychiatry 47 (2000) 548-556
185. 2A/2C) receptors. J. Pharmacol. Exp. Ther. 271 (1994) 1647-1655
186. Ryu S.H., Lee S.H., Lee H.J., Cha J.H., Ham B.J., Han C.S., Choi M.J., and Lee M.S. Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 49 (2004) 174-177
187. Sabban E.L., Hebert M.A., Liu X., Nankova B., and Serova L. Differential effects of stress on gene transcription factors in catecholaminergic systems. Ann. NY Acad. Sci. 1032 (2004) 130-140
188. Sachar E.J., Hellman L., Fukushima D.K., and Gallagher T.F. Cortisol production in depressive illness. Arch. Gen. Psychiatry 23 (1970) 289-298
189. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A.C., Berman R.M., Charney D.S., and Krystal J.H. Reduced cortical g-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56 (1999) 1043-1047
190. Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., and Van de Kar L.D. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. J. Neurosci. 20 (2000) 3095-3103
191. Serretti A., and Smeraldi E. Dopamine D2 receptor gene not associated with symptomatology of mood disorders. Am. J. Med. Genet. 88 (1999) 294-297
192. Serretti A., Lilli R., Lorenzi C., Franchini L., Di Bella D., Catalano M., and Smeraldi E. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Psychiatry Res. 87 (1999) 7-19
193. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Di Bella D., Catalano M., and Smeraldi E. GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. Psychiatr. Genet. 8 (1998) 251-254
194. Shimizu N., Take S., Hori T., and Oomura Y. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: Significant enhancement by immobilization stress in rats. Brain Res. Bull. 28 (1992) 727-734
195. Shioe K., Ichimiya T., Suhara T., Takano A., Sudo Y., Yasuno F., Hirano M., Shinohara M., Kagami M., Okubo Y., Nankai M., and Kanba S. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48 (2003) 184-188
196. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 7 (2002) 579-593
197. Smagin G.N., Swiergiel A.H., and Dunn A.J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res. Bull. 36 (1995) 71-76
198. Smith G.S., Lotrich F.E., Malhotra A.K., Lee A.T., Ma Y., Kramer E., Gregersen P.K., Eidelberg D., and Pollock B.G. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 29 12 (2004) 2226-2234
199. Smoller J.W., and Finn C.T. Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet. 123C (2003) 48-58
200. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (1990) 146-151
201. Souery D., Van Gestel S., Massat I., Blairy S., Adolfsson R., Blackwood D., Del Favero J., Dikeos D., Jakovljevic M., Kaneva R., Lattuada E., Lerer B., et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A multicenter association study. Biol. Psychiatry 49 (2001) 405-409
202. Stefulj J., Buttner A., Skavic J., Zill P., Balija M., Eisenmenger W., Bondy B., and Jernej B. Serotonin 1B (5HT-1B) receptor polymorphism (G861C) in suicide victims: Association studies in German and Slavic population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127 (2004) 48-50
203. Stein M.B., Yehuda R., Koverola C., and Hanna C. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol. Psychiatry 42 (1997) 680-686
204. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., and Little K.Y. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am. J. Med. Genet. 114 (2002) 230-234
205. Strauss J., Barr C.L., George C.J., King N., Shaikh S., Devlin B., Kovacs M., and Kennedy J.L. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131 (2004) 16-19
206. Sullivan P.F., Neale M.C., and Kendler K.S. Genetic epidemiology of major depression: Review and meta-analysis. Am. J. Psychiatry 157 (2000) 1552-1562
207. Tabuchi A., Sakaya H., Kisukeda T., Fushiki H., and Tsuda M. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J. Biol. Chem. 277 (2002) 35920-35931
208. The Global Burden of Disease. "A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020." (1996), Harvard School of Public Health
209. Trentani A., Kuipers S.D., Ter Horst G.J., and Den Boer J.A. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: Implications for stress-related cortical pathology?. Eur. J. Neurosci. 15 (2002) 1681-1691
210. Tsai S.J., Cheng C.Y., Yu W.-Y., Chen T.J., and Hong C.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. 123B (2003) 19-22
211. Tsuang M.T., and Faraone S.V. The inheritance of mood disorders. In: Hall L.L. (Ed). "Genetics and Mental Illness. Evolving Issues for Research and Society" (1996), Plenum Press, New York 79-109
212. Turecki G., Sequeira A., Gingras Y., Seguin M., Lesage A., Tousignant M., Chawky N., Vanier C., Lipp O., Benkelfat C., and Rouleau G.A. Suicide and serotonin: Study of variation at seven serotonin receptor genes in suicide completers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 118 (2003) 36-40
213. Van de Kar L.D., and Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front. Neuroendocrinol. 20 (1999) 1-48
214. Van de Kar L.D., Javed A., Zhang Y., Serres F., Raap D.K., and Gray T.S. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J. Neurosci. 21 (2001) 3572-3579
215. van West D., Del Favero J., Aulchenko Y., Oswald P., Souery D., Forsgren T., Sluijs S., Bel-Kacem S., Adolfsson R., Mendlewicz J., Van Duijn C., Deboutte D., et al. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol. Psychiatry 9 (2004) 287-292
216. Vincent J.B., Masellis M., Lawrence J., Choi V., Gurling H.M.D., Phil M., Parikh S.V., and Kennedy J.L. Genetic association analysis of serotonin system genes in bipolar affective disorder. Am. J. Psychiatry 156 (1999) 136-138
217. Vogt I.R., Shimron-Abarbanell D., Neidt H., Erdmann J., Cichon S., Schulze T.G., Muller D.J., Maier W., Albus M., Borrmann-Hassenbach M., Knapp M., Rietschel M., et al. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 96 (2000) 217-221
218. Wender P.H., Kety S.S., Rosenthal D., Schulsinger F., Ortmann J., and Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch. Gen. Psychiatry 43 (1986) 923-929
219. Whitnall M.H., Kiss A., and Aguilera G. Contrasting effects of central alpha-1-adrenoreceptor activation on stress-responsive and stress-nonresponsive subpopulations of corticotropin-releasing hormone neurosecretory cells in the rat. Neuroendocrinology 58 (1993) 42-48
220. Willeit M., Stastny J., Pirker W., Praschak-Rieder N., Neumeister A., Asenbaum S., Tauscher J., Fuchs K., Sieghart W., Hornik K., Aschauer H.N., Brucke T., et al. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol. Psychiatry 50 (2001) 8-12
221. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 28 (2003) 533-541
222. Wiste A.K., Underwood M.D., Ellis S.P., Mann J.J., and Arango V. Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder. Biol. Psychiatry (2005) (in press)
223. Wust S., Federenko I.S., VAN Rossum E.F., Koper J.W., and Hellhammer D.H. Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 30 (2005) 199-211
224. Wust S., Federenko I.S., VAN Rossum E.F., Koper J.W., Kumsta R., Entringer S., and Hellhammer D.H. A psychobiological perspective on genetic determinants of hypothalamus-pituitary-adrenal axis activity. Ann. NY Acad. Sci. 1032 (2004) 52-62
225. Wu W.H., Huo S.J., Cheng C.Y., Hong C.J., and Tsai S.J. Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders. Neuropsychobiology 44 (2001) 172-175
226. Young E.A., Abelson J.L., Curtis G.C., and Nesse R.M. Childhood adversity and vulnerability to mood and anxiety disorders. Depress. Anxiety 5 (1997) 66-72
227. Young E.A., Watson S.J., Kotun J., Haskett R.F., Grunhaus L., Murphy-Weinberg V., Vale W., Rivier J., and Akil H. Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies. Arch. Gen. Psychiatry 47 (1990) 449-457
228. Zalsman G., Huang Y., Oquendo M.A., Burke A., Hu X., Brent D.A., Goldman D., and Mann J.J. A triallelic serotonin transporter gene promoter polymorphism (5-HTTLPR), stressful life events and severity of depression. Am. J. Psychiatry (2005) (in press)
229. Zanardi R., Benedetti F., Di Bella D., Catalano M., and Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J. Clin. Psychopharmacol. 20 (2000) 105-107
230. Zanardi R., Serretti A., Rossini D., Franchini L., Cusin C., Lattuada E., Dotoli D., and Smeraldi E. Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol. Psychiatry 50 (2001) 323-330
231. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., Moller H.J., Bondy B., and Ackenheil M. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry 9 (2004) 1030-1036
232. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., and Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry 56 (2004) 581-586
233. Zill P., Engel R., Baghai T.C., Juckel G., Frodl T., Muller-Siecheneder F., Zwanzger P., Schule C., Minov C., Behrens S.M.T.A., Rupprecht R., Hegerl U., et al. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 26 (2002) 489-493
234. Zubenko G.S., Hughes III H.B., Maher B.S., Stiffler J.S., Zubenko W.N., and Marazita M.L. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am. J. Med. Genet. 114 (2002) 980-987
235. Zubenko G.S., Maher B., Hughes III H.B., Zubenko W.N., Stiffler J.S., Kaplan B.B., and Marazita M.L. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am. J. Med. Genet. 123B (2003) 1-18